Structural and In Vitro Functional Comparability Analysis of Altebrel™, a Proposed Etanercept Biosimilar: Focus on Primary Sequence and Glycosylation
The demand for reliable comparability studies of biosimilars grows with their increased market share. These studies focus on physicochemical, structural, functional and clinical properties to ensure that a biosimilar has no significant differences to the originator product and can be released into t...
Saved in:
Main Authors: | Ramin Fazel (Author), Yudong Guan (Author), Behrouz Vaziri (Author), Christoph Krisp (Author), Laura Heikaus (Author), Amirhossein Saadati (Author), Siti Nurul Hidayah (Author), Manasi Gaikwad (Author), Hartmut Schlüter (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020) -
Etanercept biosimilar associated with Guillain-Barré syndrome: insights from a case
by: V. Shobha, et al.
Published: (2019) -
Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
by: Nuria Carballo, et al.
Published: (2022) -
Population Pharmacokinetic Analysis and Simulation of Alternative Dosing Regimens for Biosimilars to Adalimumab and Etanercept in Patients with Rheumatoid Arthritis
by: Stephanie F. Ling, et al.
Published: (2024) -
Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: A meta-analysis
by: Rui Hu, et al.
Published: (2023)